ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

2422 studies

261–280 of 2,422 studies

E3 PreliminaryMechanismPEM not requiredMechanistic

Lacticaseibacillus rhamnosus Strains for Alleviation of Irritable Bowel Disease and Chronic Fatigue Syndrome.

Zhang, Liang, Ni, Xue, Jiang, Minzhi et al.·Microorganisms·2024

Researchers studied special strains of a probiotic bacteria called Lacticaseibacillus rhamnosus to see if they could help with ME/CFS and irritable bowel syndrome (IBS). After testing 21 different strains, they found that two strains (WL11 and WL17) reduced fatigue-related symptoms like weight loss, anxiety, and memory problems in mice with CFS-like illness, and also eased IBS symptoms like gut sensitivity and inflammation. However, these results are from animal studies, so we don't yet know if the same effects will work in people.

Immune System

E3 PreliminaryMechanismPEM requiredMechanistic

Post-exertional malaise - A functional brain aberration?

Bruun Bratholm Wyller, Vegard·Brain, behavior, and immunity·2024

This study explores whether post-exertional malaise (PEM)—the hallmark symptom of ME/CFS where activity makes symptoms worse—might be caused by problems in how the brain functions. Researchers examined brain activity patterns in ME/CFS patients to understand what happens after exertion. The findings suggest that brain function abnormalities could play a role in why patients experience this debilitating symptom.

Post-Exertional Malaise

E3 PreliminaryReviewPEM not requiredReview-Narrative

Cardiac Geometry and Function in Patients with Reflex Syncope.

Coseriu, Giorgia, Schiop-Tentea, Patricia, Apetrei, Csilla-Andrea et al.·Journal of clinical medicine·2024

This review examines how the size and function of the heart relate to fainting episodes in people with reflex syncope. Researchers found that people with smaller hearts and very forceful heartbeats are more prone to fainting, and this pattern is also seen in some people with chronic fatigue syndrome. Understanding these heart differences may help doctors predict who will faint again and choose better treatments.

Autonomic Nervous System

E3 PreliminaryCohortPEM requiredCase-Control

Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19.

McAlpine, Lindsay, Zubair, Adeel S, Joseph, Phillip et al.·Neurology(R) neuroimmunology & neuroinflammation·2024

This study looked at 16 patients who developed nerve damage in their small nerves after COVID-19. The researchers found that 92% of these patients also had symptoms of ME/CFS, including post-exertional malaise (feeling much worse after activity). When 9 patients were treated with IVIG (an immune therapy), all of them improved significantly, while only 3 out of 7 untreated patients improved.

Post-Exertional Malaise

E3 PreliminaryReviewPEM requiredReview-Narrative

Post-Acute Sequelae of SARS-CoV-2 Infections: Exercise Limitation and Rehabilitation.

Mathew, Joscilin, Nugent, Kenneth·The Yale journal of biology and medicine·2024

Some people who had COVID-19 develop long-lasting symptoms and struggle with exercise—a condition called long COVID. This article explains that exercise problems can happen for different reasons: heart issues, lung problems, weak muscles, being out of shape, or symptoms that seem worse than what physical tests show. While many patients improve with standard rehabilitation programs, those with post-exertional malaise (getting worse after activity) need special, carefully monitored exercise plans.

Post-Exertional Malaise

E3 PreliminaryReviewPEM unclearReview-Narrative

Current understanding of nociplastic pain.

Yoo, Yeong-Min, Kim, Kyung-Hoon·The Korean journal of pain·2024

This article explains 'nociplastic pain'—a type of chronic pain that occurs when the nervous system becomes overly sensitive to pain signals, even when there is no obvious tissue damage or nerve injury. People with ME/CFS, fibromyalgia, and similar conditions often experience this kind of pain. The article describes how doctors can recognize nociplastic pain and groups it with other conditions that share this same underlying mechanism of nervous system sensitivity.

Pain and Sensitization

E3 PreliminaryGuidelinePEM unclearGuideline

Improving quality in adult long covid services: Findings from the LOCOMOTION quality improvement collaborative.

Darbyshire, Julie, Greenhalgh, Trisha, Bakerly, Nawar D et al.·Clinical medicine (London, England)·2024

This study looked at how ten long COVID clinics across the UK could improve their care for patients by sharing what they were learning with each other. From 2021 to 2023, clinic staff and patients met regularly to discuss the best ways to help people with long COVID, focusing on problems like breathing difficulties, heart rate issues, tiredness, and brain fog. The team created practical guides to help doctors provide better, more consistent care.

Autonomic Nervous SystemCognitive Impairment

E3 PreliminaryMechanismPEM not requiredMechanistic

Repeated cold stress, an animal model for fibromyalgia, elicits proprioceptor-induced chronic pain with microglial activation in mice.

Wakatsuki, Koji, Kiryu-Seo, Sumiko, Yasui, Masaya et al.·Journal of neuroinflammation·2024

Researchers used mice exposed to repeated cold stress to study how chronic pain develops, similar to fibromyalgia. They found that sensory nerve cells (proprioceptors) become overactive and trigger immune cells in the nervous system called microglia to become inflamed. When they reduced microglial activity with a drug, the pain improved, suggesting that this immune activation along nerve pathways may be a key driver of long-lasting pain.

Neuroinflammation

E3 PreliminaryCommentaryPEM not requiredEditorial

What Makes It Tick: Exploring the Mechanisms of Post-treatment Lyme Disease Syndrome.

Wester, Kate E, Nwokeabia, Bianca C, Hassan, Rehana et al.·Cureus·2024

This article discusses Post-treatment Lyme disease Syndrome (PTLDS), a condition where some people experience lasting fatigue, pain, and thinking problems for more than six months after being treated with antibiotics for Lyme disease. The authors suggest these symptoms may result from the body's immune system continuing to react to damage caused by the Lyme bacteria, even after the infection is gone. Currently, there is no blood test or scan to diagnose PTLDS, so doctors rely on patient symptoms and medical history.

Immune System

E3 PreliminaryPEM unclear

A suffering body, hidden away from others: The experience of being long-term bedridden with severe myalgic encephalomyelitis/chronic fatigue syndrome in childhood and adolescence.

Krabbe, Silje Helen, Bjorbækmo, Wenche Schrøder, Mengshoel, Anne Marit et al.·Nursing inquiry·2024

This study explored how young women experienced being severely ill with ME/CFS during their teenage years, looking back from a point where they had recovered or improved. Researchers interviewed 13 women aged 16-29 about their memories of being bedridden and isolated. The study found that patients often felt caught between wanting company and needing to be alone, experienced their bodies as fragile and unstable, endured long periods of darkness and isolation, and eventually had to make sense of these painful memories as they recovered.

Severe ME

E3 PreliminaryBehavioralPEM not requiredCross-Sectional

A taxonomy of threat and soothing influences in rheumatic and musculoskeletal diseases and central sensitivity syndromes.

Hijne, Kim, Gerritsen, Lotte, Pinto, Ana M et al.·International journal of clinical and health psychology : IJCHP·2024

This study asked nearly 700 people with ME/CFS, fibromyalgia, and related conditions what makes their symptoms worse and what helps them feel better. Researchers then organized these responses into 8 types of 'threats' (things that worsen symptoms, like stress or overactivity) and 10 types of 'soothers' (things that help, like rest, support from others, and understanding). The results create a practical checklist that doctors and patients can use together to identify what triggers each person's symptoms and what treatments might help most.

E3 PreliminaryMechanismPEM not requiredLongitudinal

Time-dependent complexity characterisation of activity patterns in patients with Chronic Fatigue Syndrome.

Rabaey, Paloma, Decat, Peter, Heytens, Stefan et al.·BioPsychoSocial medicine·2024

Researchers tracked the physical activity patterns of 7 ME/CFS patients over 3 weeks to see if the complexity of how they move changes over time and relates to how well they're functioning. They found that each patient's activity complexity varied significantly from week to week, and these changes didn't consistently match whether patients reported feeling better or worse. This suggests that measuring activity patterns alone may not be a reliable way to track how ME/CFS patients are doing.

Autonomic Nervous System

E3 PreliminaryMechanismPEM unclearMechanistic

Potential pathophysiological role of the ion channel TRPM3 in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and the therapeutic effect of low-dose naltrexone.

Löhn, Matthias, Wirth, Klaus Josef·Journal of translational medicine·2024

This study explores how a specific ion channel called TRPM3, which helps control pain signals and immune cell function, may not work properly in ME/CFS patients. The researchers found that immune cells called natural killer cells have reduced function due to TRPM3 problems, and a medication called low-dose naltrexone (LDN) may help restore this function in laboratory tests. This could explain why some ME/CFS patients report feeling better with LDN treatment.

Immune System

E3 PreliminaryCohortPEM requiredCase-Control

Mitochondrial DNA Missense Mutations ChrMT: 8981A > G and ChrMT: 6268C > T Identified in a Caucasian Female with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Triggered by the Epstein-Barr Virus.

Tang-Siegel, Gaoyan G, Maughan, David W, Frownfelter, Milah B et al.·Case reports in genetics·2024

This study describes one patient with ME/CFS whose symptoms began after a severe viral infection (Epstein-Barr virus, which causes mononucleosis) 24 years ago. Researchers found that her cells had genetic mutations affecting the mitochondria—the 'power plants' that produce energy for our bodies—which may explain her extreme fatigue and difficulty recovering from physical activity. The study also found abnormal mitochondria circulating in her blood, suggesting that energy production problems may be contributing to her ME/CFS symptoms.

Post-Exertional Malaise

E3 PreliminaryMechanismPEM unclearMechanistic

Widespread Myalgia and Chronic Fatigue: Phagocytes from Macrophagic Myofasciitis Patients Exposed to Aluminum Oxyhydroxide-Adjuvanted Vaccine Exhibit Specific Inflammatory, Autophagic, and Mitochondrial Responses.

Masson, Jean-Daniel, Badran, Ghidaa, Gherardi, Romain K et al.·Toxics·2024

This study examined immune cells from people with macrophagic myofasciitis (MMF), a condition involving long-term inflammation from vaccine aluminum adjuvants lodged in muscle tissue. Researchers found that these immune cells behave abnormally when exposed to aluminum adjuvants: they produce more pain-causing molecules, show signs of energy exhaustion, and struggle to respond to their normal workload. These findings suggest a possible mechanism for why MMF patients develop severe fatigue and widespread muscle pain similar to ME/CFS.

Energy MetabolismImmune System

E3 PreliminaryMechanismPEM unclearCross-Sectional

Dysregulation of the Kynurenine Pathway, Cytokine Expression Pattern, and Proteomics Profile Link to Symptomology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Kavyani, Bahar, Ahn, Seong Beom, Missailidis, Daniel et al.·Molecular neurobiology·2024

This study found that ME/CFS patients have imbalances in a particular chemical pathway in their body (the kynurenine pathway) that appears connected to inflammation and symptom severity. The researchers discovered that higher levels of one early chemical in this pathway correlated with worse symptoms, while lower levels of later chemicals in the pathway might affect how cells produce energy. Interestingly, they also found that five of the most significantly changed proteins in ME/CFS patients are involved in gut health, suggesting the gut microbiome may play an important role in the disease.

BiomarkersGut MicrobiomeEnergy MetabolismImmune System

E3 PreliminaryReviewPEM unclearReview-Narrative

Current update on the neurological manifestations of long COVID: more questions than answers.

Stefanou, Maria-Ioanna, Panagiotopoulos, Evangelos, Palaiodimou, Lina et al.·EXCLI journal·2024

This review examines the nerve and brain-related symptoms that can persist after COVID-19 infection, which doctors call long COVID. About one-third of COVID-19 survivors experience lasting neurological problems such as fatigue, brain fog, sleep issues, and problems with smell or taste that can last at least 12 months. The authors discuss what we currently know about why these symptoms happen and what treatments might help.

NeuroinflammationPost-Exertional Malaise

E3 PreliminaryReviewPEM unclearReview-Narrative

Nutrition and Chronobiology as Key Components of Multidisciplinary Therapeutic Interventions for Fibromyalgia and Associated Chronic Fatigue Syndrome: A Narrative and Critical Review.

Carrasco-Querol, Noèlia, Cabricano-Canga, Lorena, Bueno Hernández, Nerea et al.·Nutrients·2024

This review examines how diet and body rhythms (sleep-wake cycles) affect fibromyalgia and chronic fatigue syndrome. The authors found that what you eat, nutrient levels, gut bacteria, and your natural circadian rhythm all play important roles in these conditions. They conclude that treating FM/CFS effectively requires paying attention to nutrition and sleep timing alongside other therapies.

Sleep

E3 PreliminaryReviewPEM unclearReview-Narrative

Sex differences in vascular endothelial function related to acute and long COVID-19.

Kitselman A, Kayla, Bédard-Matteau, Jérôme, Rousseau, Simon et al.·Vascular pharmacology·2024

This review examines how COVID-19 and long COVID affect blood vessel health differently in men and women. The authors look at how the virus can damage the inner lining of blood vessels, trigger immune problems, and potentially lead to ME/CFS symptoms. They explore whether biological sex differences explain why some people recover while others develop long-term symptoms like fatigue.

Immune System

E3 PreliminaryReviewPEM unclearReview-Narrative

Conceptual foundations of acetylcarnitine supplementation in neuropsychiatric long COVID syndrome: a narrative review.

Helbing, Dario Lucas, Dommaschk, Eva-Maria, Danyeli, Lena Vera et al.·European archives of psychiatry and clinical neuroscience·2024

This review examines whether a natural supplement called acetylcarnitine might help treat long COVID symptoms like fatigue, brain fog, and depression. Acetylcarnitine is a substance your body normally makes that helps cells produce energy. The authors looked at research showing this supplement has helped some people with similar illnesses like ME/CFS and depression, and they propose studying whether it could help long COVID patients too.

Neuroinflammation

← Previous Next 20 studies →

Or browse by topic

PEM Immune Neuro Metabolic Biomarkers Severe ME Long COVID Cognitive

Evidence Atlas

Evidence browser

Lacticaseibacillus rhamnosus Strains for Alleviation of Irritable Bowel Disease and Chronic Fatigue Syndrome.

Post-exertional malaise - A functional brain aberration?

Cardiac Geometry and Function in Patients with Reflex Syncope.

Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19.

Post-Acute Sequelae of SARS-CoV-2 Infections: Exercise Limitation and Rehabilitation.

Current understanding of nociplastic pain.

Improving quality in adult long covid services: Findings from the LOCOMOTION quality improvement collaborative.

Repeated cold stress, an animal model for fibromyalgia, elicits proprioceptor-induced chronic pain with microglial activation in mice.

What Makes It Tick: Exploring the Mechanisms of Post-treatment Lyme Disease Syndrome.

A suffering body, hidden away from others: The experience of being long-term bedridden with severe myalgic encephalomyelitis/chronic fatigue syndrome in childhood and adolescence.

A taxonomy of threat and soothing influences in rheumatic and musculoskeletal diseases and central sensitivity syndromes.

Time-dependent complexity characterisation of activity patterns in patients with Chronic Fatigue Syndrome.

Potential pathophysiological role of the ion channel TRPM3 in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and the therapeutic effect of low-dose naltrexone.

Mitochondrial DNA Missense Mutations ChrMT: 8981A > G and ChrMT: 6268C > T Identified in a Caucasian Female with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Triggered by the Epstein-Barr Virus.

Widespread Myalgia and Chronic Fatigue: Phagocytes from Macrophagic Myofasciitis Patients Exposed to Aluminum Oxyhydroxide-Adjuvanted Vaccine Exhibit Specific Inflammatory, Autophagic, and Mitochondrial Responses.

Dysregulation of the Kynurenine Pathway, Cytokine Expression Pattern, and Proteomics Profile Link to Symptomology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Current update on the neurological manifestations of long COVID: more questions than answers.

Nutrition and Chronobiology as Key Components of Multidisciplinary Therapeutic Interventions for Fibromyalgia and Associated Chronic Fatigue Syndrome: A Narrative and Critical Review.

Sex differences in vascular endothelial function related to acute and long COVID-19.

Conceptual foundations of acetylcarnitine supplementation in neuropsychiatric long COVID syndrome: a narrative review.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research